Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $157,412 | 102 | 51.5% |
| Consulting Fee | $81,822 | 63 | 26.8% |
| Travel and Lodging | $41,980 | 165 | 13.7% |
| Food and Beverage | $9,188 | 211 | 3.0% |
| Honoraria | $8,550 | 9 | 2.8% |
| Unspecified | $6,400 | 2 | 2.1% |
| Education | $64.54 | 2 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $51,112 | 84 | $0 (2024) |
| PFIZER INC. | $51,014 | 32 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $41,039 | 97 | $0 (2024) |
| Exact Sciences Corporation | $36,211 | 71 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $18,884 | 39 | $0 (2021) |
| ABBVIE INC. | $18,044 | 81 | $0 (2024) |
| SANOFI PASTEUR INC. | $17,103 | 27 | $0 (2024) |
| Merck Sharp & Dohme LLC | $16,964 | 25 | $0 (2024) |
| ModernaTX, Inc. | $14,169 | 35 | $0 (2023) |
| Seqirus USA Inc | $12,153 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $104,087 | 183 | AstraZeneca Pharmaceuticals LP ($35,102) |
| 2023 | $78,787 | 152 | IDORSIA PHARMACEUTICALS US INC ($29,435) |
| 2022 | $72,866 | 133 | PFIZER INC. ($20,594) |
| 2021 | $49,677 | 86 | Biohaven Pharmaceuticals, Inc. ($18,884) |
All Payment Transactions
554 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: PAIN | ||||||
| 12/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $91.30 | General |
| Category: Respiratory | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,300.00 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | PFIZER INC. | ABRYSVO (Biological) | Travel and Lodging | In-kind items and services | $143.32 | General |
| Category: VACCINES | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $549.45 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $91.09 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $57.02 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $44.01 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Travel and Lodging | In-kind items and services | $39.68 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: VACCINE | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | PFIZER INC. | ABRYSVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: VACCINES | ||||||
| 10/15/2024 | PFIZER INC. | COMIRNATY (Biological) | Travel and Lodging | In-kind items and services | $498.48 | General |
| Category: VACCINES | ||||||
| 10/13/2024 | PFIZER INC. | ABRYSVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: VACCINES | ||||||
| 10/09/2024 | PFIZER INC. | COMIRNATY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: VACCINES | ||||||
| 10/08/2024 | PFIZER INC. | COMIRNATY (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $250.00 | General |
| Category: VACCINES | ||||||
| 10/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $30.30 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | PFIZER INC. | ABRYSVO (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,875.00 | General |
| Category: VACCINES | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| TANEZUMAB CLINICAL PUBLICATION PROGRAM | PFIZER INC. | $6,400 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 330 | 378 | $64,644 | $30,419 |
| 2022 | 12 | 409 | 506 | $72,145 | $31,688 |
| 2021 | 21 | 538 | 625 | $75,608 | $35,775 |
| 2020 | 10 | 317 | 426 | $57,664 | $22,641 |
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 131 | $32,329 | $9,801 | 30.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 65 | 65 | $13,000 | $7,144 | 55.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 16 | 16 | $5,420 | $4,507 | 83.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 33 | 33 | $2,415 | $2,258 | 93.5% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 14 | 14 | $2,450 | $1,799 | 73.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $2,700 | $1,687 | 62.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 38 | 38 | $1,140 | $1,117 | 98.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 18 | 18 | $1,200 | $741.96 | 61.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $2,260 | $614.12 | 27.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $675.00 | $463.65 | 68.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 12 | 12 | $230.00 | $188.10 | 81.8% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 11 | 11 | $825.00 | $98.60 | 12.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 114 | 190 | $44,850 | $14,500 | 32.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 70 | 70 | $14,000 | $7,999 | 57.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 49 | 49 | $3,185 | $3,121 | 98.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 11 | 11 | $3,300 | $3,064 | 92.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 51 | 51 | $1,530 | $1,499 | 98.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 17 | 17 | $765.00 | $513.79 | 67.2% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 11 | 11 | $1,100 | $334.45 | 30.4% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 13 | 15 | $1,210 | $229.22 | 18.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 13 | 20 | $600.00 | $192.26 | 32.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 13 | $975.00 | $110.49 | 11.3% |
| 81002 | Urinalysis, manual test | Office | 2022 | 17 | 20 | $240.00 | $68.99 | 28.7% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 31 | 39 | $390.00 | $54.76 | 14.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 109 | 180 | $36,150 | $13,599 | 37.6% |
About Wendy Wright, ARNP
Wendy Wright, ARNP is a Family healthcare provider based in Amherst, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346274941.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Wendy Wright, ARNP has received a total of $305,417 in payments from pharmaceutical and medical device companies, with $104,087 received in 2024. These payments were reported across 554 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($157,412).
As a Medicare-enrolled provider, Wright has provided services to 1,594 Medicare beneficiaries, totaling 1,935 services with total Medicare billing of $120,524. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Amherst, NH
- Active Since 07/10/2006
- Last Updated 03/07/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1346274941
Products in Payments
- QUVIVIQ (Drug) $41,039
- Cologuard Collection Kit (Device) $36,177
- AIRSUPRA (Drug) $23,035
- NURTEC ODT (Drug) $22,607
- BREZTRI (Drug) $18,297
- TRUMENBA (Biological) $17,415
- UBRELVY (Drug) $11,787
- ABRYSVO (Biological) $9,768
- COMIRNATY (Biological) $7,398
- NOVAVAX COVID-19 VACCINE, ADJUVANTED (Biological) $6,585
- ZAVZPRET (Drug) $5,110
- Moderna Covid-19 Vaccine (Biological) $4,989
- ACCRUFER (Drug) $4,335
- MENQUADFI (Biological) $3,736
- FLUZONE HIGH-DOSE (Biological) $3,059
- BOTOX (Biological) $2,888
- FLUCELVAX QUADRIVALENT (Biological) $2,880
- Kerendia (Drug) $2,166
- Fluad Quadrivalent (Biological) $2,000
- REJOYN (Device) $1,335
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Amherst
Juliana Frosch, Np, NP
Family — Payments: $31,834
Elena Kalabushkina
Family — Payments: $10,885
Andrea Gunnells, Fnp, FNP
Family — Payments: $10,550
Samantha Rola
Family — Payments: $10,401
Tracy Nichter
Family — Payments: $9,737
Kalina Bidjov, Fnp, FNP
Family — Payments: $8,847